Found: 147
Select item for more details and to access through your institution.
Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 7, p. 1251, doi. 10.1007/s00432-013-1438-9
- By:
- Publication type:
- Article
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
- Published in:
- Neurological Sciences, 2013, v. 34, n. 7, p. 1057, doi. 10.1007/s10072-012-1105-y
- By:
- Publication type:
- Article
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single center prospective evaluation and desensitization strategies employed.
- Published in:
- Blood Transfusion (17232007), 2024, v. 22, n. 5, p. 157, doi. 10.2450/BloodTransfus.464
- By:
- Publication type:
- Article
Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
- Published in:
- Blood Transfusion (17232007), 2024, v. 22, n. 2, p. 157, doi. 10.2450/BloodTransfus.464
- By:
- Publication type:
- Article
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation.
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 4, p. 665, doi. 10.1111/ijlh.14255
- By:
- Publication type:
- Article
Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. e120, doi. 10.1111/ijlh.13766
- By:
- Publication type:
- Article
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single‐centre experience.
- Published in:
- Vox Sanguinis, 2019, v. 114, n. 7, p. 762, doi. 10.1111/vox.12834
- By:
- Publication type:
- Article
Programming discrete distributions with chemical reaction networks.
- Published in:
- Natural Computing, 2018, v. 17, n. 1, p. 131, doi. 10.1007/s11047-017-9667-5
- By:
- Publication type:
- Article
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2023, v. 15, n. 1, p. 1, doi. 10.4084/MJHID.2023.009
- By:
- Publication type:
- Article
VEGF and IL-6 Correlation in POEMS: a Potential Upcoming Marker of Active Disease and Early Autologous BMT Response.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.007
- By:
- Publication type:
- Article
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.062
- By:
- Publication type:
- Article
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T).
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.066
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2018, v. 10, n. 1, p. 1, doi. 10.4084/MJHID.2018.005
- By:
- Publication type:
- Article
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.031
- By:
- Publication type:
- Article
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2016, v. 8, p. 1, doi. 10.4084/MJHID.2016.027
- By:
- Publication type:
- Article
The Use of Monoclonal Antibodies in the Treatment of Autoimmune Complications of Chronic Lymphocytic Leukemia.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2013, v. 5, n. 1, p. 1, doi. 10.4084/MJHID.2013.027
- By:
- Publication type:
- Article
Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2012, v. 4, n. 1, p. 1, doi. 10.4084/MJHID.2012.067
- By:
- Publication type:
- Article
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 1, p. 86, doi. 10.1111/bjh.18596
- By:
- Publication type:
- Article
Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 316, doi. 10.1111/bjh.17145
- By:
- Publication type:
- Article
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 901, doi. 10.1111/bjh.16975
- By:
- Publication type:
- Article
Unselected donor‐derived hematopoietic stem cells boost for Chimeric Antigen Receptor T‐cell associated hematotoxicity.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 751, doi. 10.1002/ajh.27208
- By:
- Publication type:
- Article
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. E157, doi. 10.1002/ajh.26927
- By:
- Publication type:
- Article
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E24, doi. 10.1002/ajh.26779
- By:
- Publication type:
- Article
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
- By:
- Publication type:
- Article
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
- By:
- Publication type:
- Article
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E306, doi. 10.1002/ajh.26235
- By:
- Publication type:
- Article
Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. E269, doi. 10.1002/ajh.26201
- By:
- Publication type:
- Article
Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E168, doi. 10.1002/ajh.26127
- By:
- Publication type:
- Article
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 234, doi. 10.1002/ajh.26042
- By:
- Publication type:
- Article
RECENT ADVANCES IN THE PATHOGENESIS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA.
- Published in:
- Contributions / Prilozi (1857-9345), 2015, v. 35, n. 3, p. 105, doi. 10.1515/prilozi-2015-0015
- By:
- Publication type:
- Article
The concomitance of lymphoma and breast carcinoma in the bone.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 941, doi. 10.1007/s00277-011-1392-z
- By:
- Publication type:
- Article
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 1, p. 59, doi. 10.1007/s00277-010-1025-y
- By:
- Publication type:
- Article
Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 5104, doi. 10.3390/jcm10215104
- By:
- Publication type:
- Article
Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy.
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1393308
- By:
- Publication type:
- Article
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2011, doi. 10.3390/cancers16112011
- By:
- Publication type:
- Article
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1228, doi. 10.3390/cancers16061228
- By:
- Publication type:
- Article
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 469, doi. 10.3390/cancers16020469
- By:
- Publication type:
- Article
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5592, doi. 10.3390/cancers15235592
- By:
- Publication type:
- Article
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5804, doi. 10.3390/cancers13225804
- By:
- Publication type:
- Article
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3240, doi. 10.3390/cancers13133240
- By:
- Publication type:
- Article
Therapeutic Targets in Chronic Lymphocytic Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1396, doi. 10.3390/cancers12061396
- By:
- Publication type:
- Article
HNRNPL Restrains miR-155 Targeting of BUB1 to Stabilize Aberrant Karyotypes of Transformed Cells in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 4, p. 575, doi. 10.3390/cancers11040575
- By:
- Publication type:
- Article
Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 493, doi. 10.1111/ejh.13573
- By:
- Publication type:
- Article
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8468, doi. 10.1002/cam4.3470
- By:
- Publication type:
- Article